The surgical gloves market is projected to exhibit significant growth by 2027 owing to rising incidences of chronic diseases that require surgical interventions.

Surgical gloves act as a barrier to prevent disease transmission between healthcare workers and patients during surgical procedures. The demand for surgical gloves has escalated after the onset of the COVID-19 pandemic for curtailing the transmission of the novel coronavirus from the infected patient to the medical professional.

Furthermore, major industry players are implementing strategic initiatives to gain a competitive edge in the market, which has been favorable for the business scenario. For instance, in January 2021, Ansell Limited, a leading protective equipment manufacturer, announced the acquisition of the Primus brand, the life science business of Primus Gloves and Sanrea Healthcare Products. The deal enabled Ansell to expand its business by leveraging Primus' significant presence in the Indian pharmaceutical manufacturing market.

The surgical gloves market has been segmented based on usage, product, sterility, form, distributional channel, end-use, and region. In terms of product, the market has further been classified into neoprene gloves, latex gloves, vinyl gloves, nitrile gloves, and others.

The nitrile gloves sub-segment held a significant market share with a valuation of over USD 1,821 million in 2020 and is predicted to grow at a steady pace over 2021-2027. Clinical benefits and latex-free composite offered by nitrile gloves are set to bolster segmental growth over the coming years.

Based on form, the market has been bifurcated into powdered gloves and powder-free gloves. In 2020, the powdered gloves sub-segment attained a valuation of around USD 319 million and is anticipated to witness robust growth over the projected period owing to high affordability and easy donning of these gloves.

With respect to usage, the surgical gloves market has been divided into disposable gloves and reusable gloves. The reusable gloves sub-segment garnered sizable valuation of around USD 847 million in 2020 and is expected to showcase optimistic growth over the study period driven by the higher strength, durability, and flexibility of these gloves.

By sterility, the market has been categorized into non-sterile gloves and sterile gloves. In 2020, the sterile gloves sub-segment exceeded a valuation of USD 3,640 million and is foreseen to expand at a solid pace through 2027. Soaring number of surgical procedures, coupled with optimum protection offered by sterile gloves in clinical settings, is likely to boost product demand over the stipulated timeframe.

In terms of distribution channel, the market has been segregated into e-commerce and brick and mortar. The e-commerce sub-segment was valued at over USD 1,296 million in 2020 and is projected to observe stable revenue growth through the review period. Surging preference for e-commerce platforms, increasing use of e-commerce platforms during the COVID-19 pandemic, and the entry of notable players into the market are set to drive segmental expansion in the future.

Based on end-use, the market has been categorized into clinics, ambulatory surgical centers, hospitals, diagnostic centers, and others. The surgical gloves market from the ambulatory surgical centers sub-segment is speculated to reach a valuation of more than USD 1,680 billion by 2027, growing at a solid CAGR through the analysis period. Escalating number of surgical procedures, along with high adoption of medical gloves, is estimated to fuel market growth over the forthcoming years.

From the regional perspective, the Middle East & Africa surgical gloves market surpassed a valuation of USD 262 million in 2020 and is likely to amass substantial gains by 2027 primarily driven by growing awareness about hygiene and mounting product adoption across the MEA region.